AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.
Phyton Biotech Partners with PellePharm to Develop Renewable Supply of Cyclopamine for Investigational Topical Cancer Therapy
Phyton Biotech partners with PellePharm.
Agenus’ R&D Project Funded by Bill & Melinda Gates Foundation Employs PCF® Technology for Potent Vaccine Ingredient
Phyton Biotech is pleased to announce the promotion of Bryan Radu to General Manager.
DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in healthcare, announced the promotion of Colin Marr to President of Phyton Ltd.
Phyton Biotech Wins Grant to Develop New Approaches [...]